Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 6
2006 8
2007 3
2008 3
2009 2
2010 4
2011 3
2012 2
2013 1
2014 2
2015 4
2016 5
2017 6
2018 6
2019 5
2020 10
2021 10
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Genetics of intellectual disability in consanguineous families.
Hu H, Kahrizi K, Musante L, Fattahi Z, Herwig R, Hosseini M, Oppitz C, Abedini SS, Suckow V, Larti F, Beheshtian M, Lipkowitz B, Akhtarkhavari T, Mehvari S, Otto S, Mohseni M, Arzhangi S, Jamali P, Mojahedi F, Taghdiri M, Papari E, Soltani Banavandi MJ, Akbari S, Tonekaboni SH, Dehghani H, Ebrahimpour MR, Bader I, Davarnia B, Cohen M, Khodaei H, Albrecht B, Azimi S, Zirn B, Bastami M, Wieczorek D, Bahrami G, Keleman K, Vahid LN, Tzschach A, Gärtner J, Gillessen-Kaesbach G, Varaghchi JR, Timmermann B, Pourfatemi F, Jankhah A, Chen W, Nikuei P, Kalscheuer VM, Oladnabi M, Wienker TF, Ropers HH, Najmabadi H. Hu H, et al. Among authors: bahrami g. Mol Psychiatry. 2019 Jul;24(7):1027-1039. doi: 10.1038/s41380-017-0012-2. Epub 2018 Jan 4. Mol Psychiatry. 2019. PMID: 29302074
Targeted protein modification as a paradigm shift in drug discovery.
Amirian R, Azadi Badrbani M, Izadi Z, Samadian H, Bahrami G, Sarvari S, Abdolmaleki S, Nabavi SM, Derakhshankhah H, Jaymand M. Amirian R, et al. Among authors: bahrami g. Eur J Med Chem. 2023 Nov 15;260:115765. doi: 10.1016/j.ejmech.2023.115765. Epub 2023 Aug 29. Eur J Med Chem. 2023. PMID: 37659194 Review.
Immunoengineering Biomaterials in Cell-Based Therapy for Type 1 Diabetes.
Derakhshankhah H, Sajadimajd S, Jahanshahi F, Samsonchi Z, Karimi H, Hajizadeh-Saffar E, Jafari S, Razmi M, Malvajerd SS, Bahrami G, Razavi M, Izadi Z. Derakhshankhah H, et al. Among authors: bahrami g. Tissue Eng Part B Rev. 2022 Oct;28(5):1053-1066. doi: 10.1089/ten.TEB.2021.0134. Epub 2022 Apr 4. Tissue Eng Part B Rev. 2022. PMID: 34696626 Review.
Momordica charantia reverses type II diabetes in rat.
Malekshahi H, Bahrami G, Miraghaee S, Ahmadi SA, Sajadimajd S, Hatami R, Mohammadi B, Keshavarzi S. Malekshahi H, et al. Among authors: bahrami g. J Food Biochem. 2019 Nov;43(11):e13021. doi: 10.1111/jfbc.13021. Epub 2019 Aug 23. J Food Biochem. 2019. PMID: 31441956
74 results